Interventional Pain Management
Mayank Gupta, MD
Mayank Gupta, MD
Learning Objectives
(1) Identify common chronic pain conditions that cause low back pain.
(2) Recognize challenges associated with managing Chronic Pain
(3) Discuss evidence based minimally invasive interventions available for chronic pain patients.
(4) Examine appropriate minimally invasive interventions to help patient population suffering with Chronic Low Back Pain.
(1) Identify common chronic pain conditions that cause low back pain.
(2) Recognize challenges associated with managing Chronic Pain
(3) Discuss evidence based minimally invasive interventions available for chronic pain patients.
(4) Examine appropriate minimally invasive interventions to help patient population suffering with Chronic Low Back Pain.
To receive CME/CE credit you must fill out the CME evaluation below!
Other Resources
Target Audience: Physicians, Nurse Practitioners, Physician Assistants, Nurses, Medical Technicians, Pharmacists, Psychologists, Physical Therapists and other healthcare professionals that treat pain conditions.
ACCREDITATION/DESIGNATION STATEMENTS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and the American Chronic Pain Association (ACPA). Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
Primary Care Network designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associates/Physician Assistants
PAs may claim a maximum of 0.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners/Nurses
The American Academy of Nurse Practitioners Certification Board (AANPCB) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Other Healthcare Professionals
All other healthcare professionals will receive a certificate of participation.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by educational grants from Averitas Pharma, Inc., Collegium Pharmaceutical Inc., and Salix Pharmaceuticals.
ACTIVITY OVERVIEW – This activity on Interventional Pain Management was captured at the ACPA Inspire Pain Freedom CME Conference. This 30-minute presentation will cover common chronic pain conditions that cause low back pain and the challenges associated with managing Chronic Pain. It covers evidence based minimally invasive interventions available for chronic pain patients and examines appropriate minimally invasive interventions to help patient population suffering with Chronic Low Back Pain.
FACULTY/CONTENT DEVELOPER
Mayank Gupta, MD
PRESIDENT KANSAS SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS
CEO Kansas Pain Management
Adjunct Clinical Assistant Professor,
Kansas City University
FACULTY/PLANNING COMMITTEE DISCLOSURES
All relevant financial relationships have been mitigated for this activity.
Mayank Gupta, MD – Faculty, Content Developer
Advisory Board: Nevro Corp., Foundation Fusion Solutions/CornerLoc (relationship has ended)
Consultant: Nevro Corp., Averitas Pharma, Nalu Medical, Foundation Fusion Solutions/CornerLoc (relationship has ended), SPR Therapeutics (relationship has ended), Vertos Grants: Nevro Corp., Averitas Pharma, Nalu Medical, Foundation Fusion Solutions/CornerLoc (relationship has ended), SPR Therapeutics (relationship has ended), Vertos, Grunenthal, Scilex, Stratus, Boston Scientific, SGX-Nova, Sollis
Research: Nevro Corp. (relationship has ended), Averitas Pharma, Nalu Medical (relationship has ended), Foundation Fusion Solutions/CornerLoc (relationship has ended), SPR Therapeutics (relationship has ended), Vertos (relationship has ended), Grunenthal, Scilex (relationship has ended), Stratus, Boston Scientific, SGX-Nova (relationship has ended), Sollis
Speaker’s Bureau: Nevro Corp., Averitas Pharma, Nalu Medical, Foundation Fusion Solutions/CornerLoc (relationship has ended), Vertos
The individuals below have had no relevant relationships within the past 24 months:
Kathy Sapp – Program Planner
Chief Executive Officer, ACPA
Scott Farmer, MBA – Program Planner
Chief Operating Officer, ACPA
Brian Koffman, MD – PCN CME Reviewer
Chief Medical Officer, CLL Society
Jill Hays, CHCP – PCN CME Reviewer
Executive Director, Primary Care Network
Cindy Fisher – PCN CME Reviewer
CME Program Manager, Primary Care Network
RELEASE/EXPIRATION DATE
This internet, enduring activity will be available for one year, beginning December 1, 2023 through December 1, 2024.
UNLABELED USE DECLARATION
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
DISCLAIMER
The opinions, ideas, recommendations, and perspectives expressed during this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards and consultants, or the activity's commercial supporter(s), if applicable.
CONTACT INFORMATION – For questions about this activity please email us at [email protected] and place Interventional Pain Management Program in the subject line.
ACCREDITATION/DESIGNATION STATEMENTS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and the American Chronic Pain Association (ACPA). Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
Primary Care Network designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associates/Physician Assistants
PAs may claim a maximum of 0.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners/Nurses
The American Academy of Nurse Practitioners Certification Board (AANPCB) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Other Healthcare Professionals
All other healthcare professionals will receive a certificate of participation.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by educational grants from Averitas Pharma, Inc., Collegium Pharmaceutical Inc., and Salix Pharmaceuticals.
ACTIVITY OVERVIEW – This activity on Interventional Pain Management was captured at the ACPA Inspire Pain Freedom CME Conference. This 30-minute presentation will cover common chronic pain conditions that cause low back pain and the challenges associated with managing Chronic Pain. It covers evidence based minimally invasive interventions available for chronic pain patients and examines appropriate minimally invasive interventions to help patient population suffering with Chronic Low Back Pain.
FACULTY/CONTENT DEVELOPER
Mayank Gupta, MD
PRESIDENT KANSAS SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS
CEO Kansas Pain Management
Adjunct Clinical Assistant Professor,
Kansas City University
FACULTY/PLANNING COMMITTEE DISCLOSURES
All relevant financial relationships have been mitigated for this activity.
Mayank Gupta, MD – Faculty, Content Developer
Advisory Board: Nevro Corp., Foundation Fusion Solutions/CornerLoc (relationship has ended)
Consultant: Nevro Corp., Averitas Pharma, Nalu Medical, Foundation Fusion Solutions/CornerLoc (relationship has ended), SPR Therapeutics (relationship has ended), Vertos Grants: Nevro Corp., Averitas Pharma, Nalu Medical, Foundation Fusion Solutions/CornerLoc (relationship has ended), SPR Therapeutics (relationship has ended), Vertos, Grunenthal, Scilex, Stratus, Boston Scientific, SGX-Nova, Sollis
Research: Nevro Corp. (relationship has ended), Averitas Pharma, Nalu Medical (relationship has ended), Foundation Fusion Solutions/CornerLoc (relationship has ended), SPR Therapeutics (relationship has ended), Vertos (relationship has ended), Grunenthal, Scilex (relationship has ended), Stratus, Boston Scientific, SGX-Nova (relationship has ended), Sollis
Speaker’s Bureau: Nevro Corp., Averitas Pharma, Nalu Medical, Foundation Fusion Solutions/CornerLoc (relationship has ended), Vertos
The individuals below have had no relevant relationships within the past 24 months:
Kathy Sapp – Program Planner
Chief Executive Officer, ACPA
Scott Farmer, MBA – Program Planner
Chief Operating Officer, ACPA
Brian Koffman, MD – PCN CME Reviewer
Chief Medical Officer, CLL Society
Jill Hays, CHCP – PCN CME Reviewer
Executive Director, Primary Care Network
Cindy Fisher – PCN CME Reviewer
CME Program Manager, Primary Care Network
RELEASE/EXPIRATION DATE
This internet, enduring activity will be available for one year, beginning December 1, 2023 through December 1, 2024.
UNLABELED USE DECLARATION
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
DISCLAIMER
The opinions, ideas, recommendations, and perspectives expressed during this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards and consultants, or the activity's commercial supporter(s), if applicable.
CONTACT INFORMATION – For questions about this activity please email us at [email protected] and place Interventional Pain Management Program in the subject line.